1.Cas No: 544-10-5
2.Molecular formula: C6H13Cl
4.Melting point : −94 °C(lit.)
5.Boiling point: 135 °C
6.Density: 0.879 g/mL at 25 °C(lit.)
7.Refractive index:n20/D 1.419(lit.)
8.Storage conditions: Flammables area
Application: 1-Chlorohexane is mainly used as a pharmaceutical synthesis intermediate and an organic synthesis intermediate, and is mainly used in the laboratory research and development process and the chemical and pharmaceutical synthesis process.
Category: Chemical intermediates; intermediates; organic building blocks; standard products; analytical standards; halogenated substances; Organics; AlkylChlorides; API Intermediate; Pyridines, HalogenatedHeterocycles; halogenated hydrocarbons; gas-phase Chemicalbook chromatography standards (color code); perfume synthesis; other raw materials; Biochemical reagents; organic chemical raw materials; chemical materials; chemical raw materials; Monofunctional&alpha,omega-BifunctionalAlkanes; MonofunctionalAlkanes.
We are Princechem Pharmaceutical manufacturer pass 20 years experience. Types of chemical reactions in are etherification, ammoniation, chlorination, esterification, cyclization, hydrogenation and Grignard reaction, etc..Over the past 10 years, more than 400 catalog products were developed. In recent years, more than 40 kinds of key pharmaceutical intermediates have been developed, involving anti-cancer, cardiovascular, digestive system, mental diseases and other fields. It includes the key intermediates of API such as Quetiapine, Fluvaxamine, Erlotinib, Gefitinib, Sunitinib, Lapatinib, Rabeprazole and Lafutidine. For many years, we have been providing high quality pharmaceutical intermediates for many world-famous pharmaceutical companies.
HI-Tech Enterprise was honored to YPC in 2011. The company adheres to scientific and technological innovation and has more than 10 authorized invention patents.
YPC insists on using the international standard management systems to promote our managements and have established the systems of ISO9001:2000, ISO14001:2004 and OHS18001:1999. Over the past few years, it has passed on-site audits by more than 20 international and domestic pharmaceutical companies.